-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Lexeo Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2022 to 2024.
- Lexeo Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$27.4M, a 82.9% decline year-over-year.
- Lexeo Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$106M, a 54.4% decline year-over-year.
- Lexeo Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$106M, a 54.4% decline from 2023.
- Lexeo Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$68.5M, a 13.2% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)